Twist Bioscience Corporation TWST
182.83
(1.20)
(0.65%)
as of 25 Sep
- Market cap
- $12.4B
- P/E
- 0.0×
Follow TWST
Growth Flags
show if company had growth for consecutive years
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.47 | 8.38 | 4.45 | 9.33 | 39.00 | 33.04 | 12.06 | 1.66 | 1.66 | 1.66 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(142.46) | (171.09) | (52.67) | (1,498.74) | (148.30) | (118.14) | (28.08) | (2.53) | (2.53) | (2.53) |
P/B ratio |
3.56 | 5.55 | 1.75 | 2.41 | 8.89 | 8.85 | 4.31 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
4.46 | 7.04 | 2.26 | 2.95 | 9.56 | 8.89 | 4.36 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.93 | 7.79 | 3.46 | 7.31 | 35.80 | 29.88 | 9.66 | (1.13) | (1.13) | (1.13) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.45 | 0.45 |
EV/Operating CF |
(31.08) | (38.05) | (5.95) | (11.97) | (42.21) | (18.92) | (5.97) | 0.44 | 0.44 | 0.44 |
EV/FCF |
(19.57) | (35.26) | (4.98) | (6.58) | (34.01) | (17.70) | (5.12) | 0.41 | 0.41 | 0.41 |
Quick Ratio |
3.17 | 4.38 | 5.19 | 6.01 | 8.03 | 8.78 | 4.95 | 4.65 | 6.81 | 6.53 |
Current Ratio |
3.64 | 4.88 | 5.79 | 6.58 | 8.67 | 9.29 | 5.28 | 5.16 | 7.16 | 6.80 |
Net Debt/EBITDA |
1.95 | 1.46 | 1.29 | 1.88 | 2.96 | 2.14 | 1.27 | 1.10 | 0.99 | 1.14 |
Debt/Assets |
2.34% | 0.00% | 12.12% | 9.87% | 7.79% | 1.19% | 4.14% | 8.39% | 10.69% | 0.00% |
Debt/Equity |
0.03 | 0.00 | 0.15 | 0.12 | 0.09 | 0.01 | 0.05 | 0.11 | 0.14 | 0.00 |
Asset Turnover |
0.60 | 0.45 | 0.28 | 0.24 | 0.24 | 0.31 | 0.36 | 0.25 | 0.25 | 0.05 |
Operating CF/Net income |
0.61 | 0.31 | 0.70 | 0.57 | 0.74 | 1.02 | 0.82 | 0.93 | 0.87 | 0.88 |
Capex/Depreciation |
(1.13) | (0.16) | (0.95) | (6.17) | (2.78) | (1.44) | (2.30) | (0.61) | (1.24) | (1.45) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (16.43%) | (38.08%) | (28.97%) | (31.80%) | (33.17%) | (57.31%) | 436.44% | 42.56% | 56.49% | 41.99% | |
| (12.37%) | (30.02%) | (23.55%) | (26.19%) | (27.63%) | (47.77%) | (71.12%) | (70.72%) | (138.48%) | (102.94%) | |
ROIC |
(33.33%) | (70.31%) | (35.61%) | (38.68%) | (60.54%) | (171.68%) | (313.39%) | (244.70%) | (276.38%) | 0.00% |
Return on Tangible Assets |
(22.59%) | (55.18%) | (42.38%) | (33.76%) | (28.83%) | (43.15%) | (71.49%) | (79.62%) | (81.00%) | (67.85%) |
Average Days of Receivables |
55.27 | 40.71 | 65.62 | 72.25 | 78.74 | 106.85 | 81.23 | 77.79 | 79.53 | 116.30 |
Research and Development Expense of Revenue |
21.32% | 29.03% | 43.61% | 59.10% | 52.20% | 47.73% | 65.61% | 80.02% | 178.03% | 803.44% |
Selling, General and Administrative Expense of Revenue |
65.59% | 69.78% | 77.41% | 104.61% | 102.70% | 114.61% | 147.33% | 170.88% | 242.04% | 805.38% |
Intangible Assets out of Total Assets |
0.15 | 0.16 | 0.18 | 0.15 | 0.06 | 0.00 | 0.01 | 0.02 | 0.02 | 0.00 |
Share Based Compensation of Revenue |
17.12% | 16.27% | 12.35% | 39.13% | 27.96% | 18.97% | 20.54% | 11.65% | 17.56% | 37.77% |
Graham Net Nets |
0.10 | 0.08 | 0.25 | 0.22 | 0.08 | 0.09 | 0.19 | 1.63 | 1.63 | 1.63 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 195.87 | 0.00 | 0.00 |
Earnings Yield |
(4.62%) | (7.97%) | (18.78%) | (11.44%) | (2.95%) | (4.94%) | (16.71%) | (182.24%) | (182.24%) | (182.24%) |
Free Cash Flow Yield |
(4.49%) | (2.64%) | (15.61%) | (11.91%) | (2.70%) | (5.11%) | (15.66%) | (165.49%) | (165.49%) | (165.49%) |
Revenue per Share |
6.30 | 5.39 | 4.31 | 3.78 | 2.74 | 2.30 | 1.98 | 9.10 | 4.45 | 1.21 |
Operating CF per Share |
(0.80) | (1.10) | (2.50) | (2.31) | (2.33) | (3.63) | (3.20) | (23.69) | (21.18) | (20.64) |
Capex per Share |
(0.47) | (0.09) | (0.49) | (1.89) | (0.56) | (0.25) | (0.54) | (1.31) | (2.61) | (3.33) |
Free Cash Flow per Share |
(1.26) | (1.19) | (2.99) | (4.20) | (2.89) | (3.88) | (3.74) | (25.00) | (23.79) | (23.97) |
Cash per Share |
3.89 | 4.76 | 5.91 | 9.37 | 9.90 | 7.40 | 5.03 | 28.91 | 25.68 | 29.90 |
Shareholders Equity per Share |
7.91 | 8.15 | 10.96 | 14.65 | 12.04 | 8.58 | 5.54 | 31.89 | 27.36 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.91 | 8.15 | 10.96 | 14.65 | 12.04 | 8.58 | 5.54 | 31.89 | 27.36 | 0.00 |
Free Cash Flow |
(75.63) | (69.17) | (170.25) | (226.24) | (139.30) | (152.12) | (102.67) | (69.83) | (57.63) | (44.82) |
Working Capital |
241.56 | 275.77 | 350.93 | 505.82 | 483.44 | 298.84 | 129.78 | 77.13 | 58.39 | 50.36 |
Capital Expenditures |
(28.00) | (5.08) | (27.78) | (101.86) | (27.06) | (9.87) | (14.74) | (3.67) | (6.33) | (6.23) |
Net Current Asset Value |
164.06 | 205.14 | 271.29 | 424.49 | 425.22 | 272.25 | 125.22 | 68.94 | 48.49 | 59.04 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.41 | 0.41 |
Capex to Sales |
0.07 | 0.02 | 0.11 | 0.50 | 0.20 | 0.11 | 0.27 | 0.14 | 0.59 | 2.75 |
Net Profit Margin |
(20.63%) | (66.69%) | (83.48%) | (107.02%) | (114.94%) | (155.31%) | (197.98%) | (280.16%) | (550.85%) | (1,943.06%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.24 | 0.31 | 0.22 | 0.12 | 0.22 | 0.27 | 0.31 | 0.49 | 0.34 | 0.29 |
Cash ROIC |
(20.81%) | (22.24%) | (26.03%) | (18.99%) | (14.04%) | (26.58%) | (36.51%) | (43.72%) | (48.05%) | (79.30%) |
Accounts Receivable Turnover |
8.19 | 7.93 | 5.81 | 5.91 | 4.82 | 4.68 | 6.21 | 6.55 | 7.02 | 1.48 |
Accounts Payable Turnover |
29.17 | 22.91 | 9.10 | 6.82 | 8.17 | 8.42 | 5.49 | 6.20 | 9.26 | 3.63 |
Inventory Turnover |
7.08 | 6.40 | 4.35 | 3.36 | 3.66 | 6.26 | 7.10 | 8.20 | 15.73 | 6.17 |
Average Days of Payables |
21.82 | 3.31 | 33.01 | 61.46 | 67.46 | 28.71 | 75.11 | 85.40 | 43.29 | 90.54 |
Days of Inventory on Hand |
55.68 | 48.93 | 75.32 | 120.23 | 143.97 | 73.05 | 56.41 | 68.35 | 27.76 | 47.58 |
Average Receivables |
45.96 | 39.48 | 42.18 | 34.42 | 27.46 | 19.24 | 8.76 | 3.88 | 1.53 | 1.53 |
Average Payables |
6.36 | 7.84 | 17.07 | 17.50 | 9.87 | 7.30 | 8.65 | 5.19 | 2.59 | 2.59 |
Average Inventory |
26.19 | 28.07 | 35.69 | 35.55 | 22.04 | 9.81 | 6.68 | 3.93 | 1.53 | 1.53 |
Average Assets |
628.09 | 695.36 | 868.89 | 831.74 | 550.49 | 292.94 | 151.39 | 100.72 | 42.83 | 42.83 |
Average Common Equity |
472.82 | 548.06 | 706.41 | 685.10 | 458.54 | 244.17 | (24.67) | (167.39) | (104.98) | (104.98) |
Columns are period end dates